Bioelectronics: addressing the biointerface challenge. This project aims to develop bioelectronic materials with long operational stability in physiological conditions and enhanced electronic performance that will effectively interface with electroresponsive tissue. These new materials will be integrated into bioadhesives from which simple bioelectronics devices will be fabricated and assessed for their capability to modulate biosignals and to interact with tissue. Disruption in biosignals cause ....Bioelectronics: addressing the biointerface challenge. This project aims to develop bioelectronic materials with long operational stability in physiological conditions and enhanced electronic performance that will effectively interface with electroresponsive tissue. These new materials will be integrated into bioadhesives from which simple bioelectronics devices will be fabricated and assessed for their capability to modulate biosignals and to interact with tissue. Disruption in biosignals causes numerous medical conditions such as epilepsy and heart failure and the development of flexible and biocompatible medical electronics devices that interface with tissue is essential for regaining and modulating these signals.Read moreRead less
Structurally Nanoengineered Antimicrobial Polypeptide Particles (SNAPPs). This project aims to develop a new platform technology for the development of antimicrobial agents by combining expertise in polymer science and antimicrobial studies. It aims to develop new nanoengineered particles for combating antibiotic-resistant bacteria, investigate the influence of particle architecture on antibacterial properties, and determine the mechanism of action. This may support the development of antibiotic ....Structurally Nanoengineered Antimicrobial Polypeptide Particles (SNAPPs). This project aims to develop a new platform technology for the development of antimicrobial agents by combining expertise in polymer science and antimicrobial studies. It aims to develop new nanoengineered particles for combating antibiotic-resistant bacteria, investigate the influence of particle architecture on antibacterial properties, and determine the mechanism of action. This may support the development of antibiotic treatments using new polypeptide particles as antibacterial drugs, resulting in advances in nanobiotechnology, polymer therapeutics and advanced materials. The outcomes may revolutionise the synthetic approach to antimicrobial peptides and contribute significantly towards current antibiotic treatments and approaches for advanced antibacterial formulations.Read moreRead less
Cell facilitated controlled radical polymerisation. This project aims to develop a controlled polymerisation method by combining reversible addition fragmentation chain (RAFT) polymerisation technology and the redox processes within bacterial cells. This polymerisation method will copy biological information in the bacterial cell surface into a growing polymer structure. Variations in the monomer structures and functionality will be used to control the incorporation of cell surface chemistry int ....Cell facilitated controlled radical polymerisation. This project aims to develop a controlled polymerisation method by combining reversible addition fragmentation chain (RAFT) polymerisation technology and the redox processes within bacterial cells. This polymerisation method will copy biological information in the bacterial cell surface into a growing polymer structure. Variations in the monomer structures and functionality will be used to control the incorporation of cell surface chemistry into the new polymer structure. Such cell-enabled controlled polymerisation could advance polymer synthesis resulting in biologically instructed polymer-mimics and new antibacterial agents.Read moreRead less
On-demand 3D polymer scaffolds for directed stem cell differentiation. The project will develop new polymer gels that can be sculpted into shapes, representing tissues and organs. This 3D scaffold will provide a surface with biological signals to create functional tissues from stem cells. The approach will create engineered intestinal tissue with great promise to increase the survival rates of colon cancer patients.